Delivery Order SPE2DB24D2101-SPE2DB25FKNDL
- Not listed
- The Defense Logistics Agency awarded a $34,684.92 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of AVEED 750 MG/3 ML vials. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 5, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $44,319.62 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on August 7, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order, which was not set aside for small business, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's distribution center in...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of AVEED 750 MG/3 ML vials. The contract, valued at $23,123.28, carries a firm fixed price and requires completion by June 23, 2025. This is a non-set-aside delivery order issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency awarded a $14.5K delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of August 12, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AVEED 750 MG/3 ML vials. This competitive, firm fixed-price delivery order, valued at $2,890.41, was executed on August 22, 2025, with an ultimate completion date of September 15, 2025. The products will be performed and delivered from AmerisourceBergen's location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,853.88 for AVEED 750 mg/3 mL vials on September 15, 2025, with an ultimate completion date of October 6, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AVEED (testosterone undecanoate) is a prescription testosterone replacement therapy indicated for treating low...
- The Defense Logistics Agency awarded a delivery order valued at $19,269.40 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on July 16, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AVEED (testosterone undecanoate) is a prescription testosterone replacement therapy indicated for...
- The Defense Logistics Agency awarded a delivery order valued at $9,634.70 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 ml vials on June 18, 2025, with completion targeted for July 11, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $19,269.40 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on April 23, 2025, with completion targeted for May 14, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. AVEED (testosterone undecanoate) is a prescription testosterone replacement therapy product, reflecting...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $72,260.25 by the Defense Logistics Agency's Medical Supply Chain for the supply of AVEED 750 mg/3 mL vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of May 16, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical....
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNDLDelivery Order
The Defense Logistics Agency awarded a $4,817.35 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for AVEED 750 mg/3 mL vials. This competitively awarded contract, with an ultimate completion date of August 27, 2025, represents a firm fixed-price transaction with no set-aside designation. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its prime IDC with DLA to fulfill critical medical supply needs across the Defense Health Agency and other federal healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. This delivery order for AVEED, a testosterone replacement therapy product, exemplifies the company's role in supporting military medical procurement requirements through open competition and flexible contract vehicles designed to meet evolving federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 8/6/25 |